News | December 18, 2025
Godavari Biorefineries launches US biotech arm to advance novel cancer therapies
The move strengthens GBL’s clinical-stage presence in the United States
The move strengthens GBL’s clinical-stage presence in the United States
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
India plays a critical role in Bristol Myers Squibb’s global strategy
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Subscribe To Our Newsletter & Stay Updated
